Signs Your Antidepressant Dose Is Too Low and What to Track

You’ve taken it every day for six weeks. Mornings are a little easier, and you cry less. But you’re still exhausted, still waking at 3 a.m., still getting through the day instead of living it. If no one has checked in to see whether the medication is actually working, it’s easy to accept “a little better” as the finish line.

Antidepressants work through a biological mechanism with a ceiling built in. SSRIs block the serotonin transporter, the protein that pulls serotonin back into nerve cells. A 2019 meta-analysis in The Lancet Psychiatry notes that brain imaging shows about 80% of transporters are occupied at minimum therapeutic doses, and its own dose-response analysis found SSRI benefit rose up to roughly 20 to 40 mg of fluoxetine equivalents before leveling off. Finding your dose is a matter of precision, because both too little and too much can leave you short of where you could be.

The standard approach is to start at a modest dose, wait several weeks, and raise it if things aren’t improving. That approach has a strong track record. In the STAR*D trial, 2,876 adults took citalopram with doses adjusted based on regular symptom ratings, reaching a mean final dose of 41.8 mg per day. Nearly half responded, and a substantial share reached response or remission at or after eight weeks. The results are real, and the method behind them is well established.

But “wait and see” without measuring can let partial response hide for months, and at Siggy we think dose decisions should rest on tracked symptoms rather than on how a single appointment happens to feel. When dosing follows measured symptoms, the dose conversation happens with data in hand. In a randomized trial comparing measurement-based care with standard care, 73.8% of patients reached remission compared with 28.8% under standard care, and they got there in about half the time.

What This Page Covers

• What “Too Low” Actually Means
• Signs Your Dose May Be Too Low
• How to Measure Your Response
• Other Reasons Your Medication May Fall Short
• Why a Higher Dose Isn’t Always Better
• How to Bring This Up With Your Prescriber
• Get Your Treatment Plan Reviewed

What “Too Low” Actually Means

A dose is too low when it hasn’t had the chance to do its full job for you. That’s different from a dose that’s numerically small. Plenty of people reach remission on a starting or modest dose.

Bodies also process these medications differently. A 2023 pharmacogenetics guideline explains that genetic variation in liver enzymes such as CYP2D6 and CYP2C19 changes how quickly many antidepressants are broken down, which can affect dosing, efficacy, and side effects. Two people on the same milligram dose can end up with very different amounts of medication in their blood.

So the question isn’t “Is my dose low?” The question is whether your symptoms have improved as much as they can on this plan.

Signs Your Dose May Be Too Low

These patterns most often point toward an undertreated dose, assuming you’ve been taking the medication every day as prescribed.

No Meaningful Change in the First Few Weeks

A 2009 meta-analysis of 6,562 patients across 41 trials found that people without at least a 20% symptom improvement within two weeks had little chance of a stable response later on. The authors suggested that changes in treatment may be worth considering earlier than tradition holds. The trials studied mirtazapine and comparison drugs, and the analysis was industry-sponsored, so it’s a signal to discuss rather than a rule.

Partial Response

You’re better, but less than half of your symptoms have lifted. Clinical trials usually define response as at least a 50% drop in symptom scores, and remission as reaching the minimal-symptom range. Feeling 20 or 30% better is real progress, and it’s also a reason to ask your prescriber how to close the rest of the gap.

Residual Symptoms That Won’t Budge

Mood improves, but sleep, energy, concentration, or interest stays stuck. Those leftovers matter. In a 1995 study of residual symptoms in depression, early relapse occurred in 76% of people who still had residual symptoms after partial remission, compared with 25% of those without them.

Progress That Stalls

You improved steadily for a few weeks and then plateaued well short of feeling like yourself. A plateau doesn’t always mean the dose is the issue, but it’s a common reason prescribers revisit the plan.

How to Measure Your Response

Memory makes a poor judge of slow change, so a symptom score gives you something firmer to work with. The PHQ-9 is a nine-question checklist you can fill out in a few minutes. The PHQ-9 validation study of 6,000 patients found scores of 5, 10, 15, and 20 marked mild, moderate, moderately severe, and severe depression.

Take it before you start or change a medication, then every week or two. Jot down sleep, energy, and anything unusual alongside the score. Our guide on how to know if your antidepressant is working covers what early response tends to look like.

This framework, built from the response and remission definitions above, can help you read your own trend:

Your Pattern	What It Suggests	What to Discuss
Little or no change by weeks 2 to 4	Lower odds of response on this plan	Whether to adjust sooner
Better, but under half your symptoms gone	Partial response	Dose change or other options
At least half better, symptoms remain	Response without remission	Aiming for remission
PHQ-9 under 5	Minimal symptom range	Staying the course, keep tracking

Other Reasons Your Medication May Fall Short

Before anyone raises a dose, it’s worth ruling out explanations that a higher dose won’t fix.

Missed or stopped doses are the most common one. In a national analysis of U.S. survey data, 42.4% of adults starting an antidepressant for depression stopped within the first 30 days, and only 27.6% continued past 90 days. Skipping doses here and there can look exactly like a dose that’s too low. Be honest with your prescriber, because it changes the plan.

Another condition may be in the mix. Anxiety, substance use, sleep disorders, or medical problems can keep symptoms going. In STAR*D, people with more co-occurring psychiatric or medical conditions had lower remission rates.

Bipolar disorder can hide behind depression. NIMH’s bipolar guide warns that treating depression with an antidepressant alone can trigger mania or rapid cycling in someone with bipolar disorder. If you’ve ever had stretches of unusually high energy with little need for sleep, tell your prescriber before any dose increase. Our post on how to stabilize your mood explains those patterns.

The medication itself may not be the right fit. Sometimes a different medication or an added treatment works better than more of the same one. Our 8-week decision path walks through those options.

Why a Higher Dose Isn’t Always Better

It’s tempting to assume more medication means more relief. The Lancet Psychiatry analysis above found that for SSRIs, benefit leveled off or even dipped through the higher licensed doses, while dropouts due to side effects rose steeply across the entire dose range. Overall acceptability was best in the lower part of the licensed range.

That doesn’t mean higher doses never help. Some people do better on them, and in the measurement-based care trial, the group that reached remission more often also had more dose adjustments and higher doses. It means a dose increase should be a targeted decision based on your response and side effects, not a reflex.

Signs a dose may be higher than you need include side effects that don’t settle after the first few weeks, like persistent nausea, sleepiness, restlessness, sexual side effects, or feeling emotionally flat. Report those instead of pushing through or stopping suddenly. Our guide to adjusting your antidepressant dose explains how changes are usually made safely.

How to Bring This Up With Your Prescriber

You don’t need to diagnose the problem. Bring the data and let your prescriber do the clinical reasoning. A short script helps:

• “I’ve taken it every day for this many weeks, with this many missed doses.”
• “My PHQ-9 went from this score to this score.”
• “Here’s what’s better, and here’s what’s still stuck.”
• “Here are the side effects I’ve noticed, and how much they bother me.”

Don’t raise or lower the dose on your own, even if you have extra pills. Self-adjusting can cause side effects or withdrawal symptoms and muddies the picture of what’s working.

If your mood gets worse, or you have thoughts of suicide or self-harm, call or text 988. If you’re in immediate danger, call 911.

Feeling partly better is progress, and it’s also information. When you track your symptoms, rule out the other explanations, and treat remission as the goal, the dose conversation becomes much clearer for you and your prescriber.

Get Your Treatment Plan Reviewed

Feeling stuck at “a little better”? Start your anonymous intake with Siggy. It’s free, it asks for no name or email, and you can lay out your current medication, dose, and leftover symptoms in your own words. A licensed prescriber reviews every treatment plan, and you get a summary and a downloadable report of your intake to share with any clinician you see.

This article is for education only and isn’t a substitute for personal medical advice. It reflects sources available as of October 2026. Talk with your own clinician before starting, changing, or stopping any medication.